Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)

HKG:2315 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	49,519	23,585	3,395	4,785	10,245	-
Market Cap Growth	882.44%	594.71%	-29.05%	-53.29%	-	-
Enterprise Value	49,255	23,859	3,562	4,682	10,003	-
Last Close Price	52.45	35.30	8.50	11.98	25.65	-
PE Ratio	64.41	122.37	95.11	-	-	-
PS Ratio	27.88	15.37	3.25	6.06	16.97	-
PB Ratio	19.05	9.72	3.80	5.50	7.87	-
P/TBV Ratio	19.53	9.99	4.13	5.73	8.12	-
P/FCF Ratio	145.94	75.04	18.32	-	-	-
P/OCF Ratio	90.55	57.24	15.10	-	-	-
EV/Sales Ratio	27.73	15.55	3.41	5.93	16.57	-
EV/EBITDA Ratio	93.06	67.88	13.92	-	-	-
EV/EBIT Ratio	129.67	101.51	25.51	-	-	-
EV/FCF Ratio	145.16	75.91	19.23	-	-	-
Debt / Equity Ratio	0.44	0.27	0.68	0.69	0.36	0.07
Debt / EBITDA Ratio	2.13	1.70	2.14	-	-	-
Debt / FCF Ratio	3.33	2.07	3.28	-	-	-
Net Debt / Equity Ratio	-0.10	-0.46	0.20	0.14	-0.20	-0.39
Net Debt / EBITDA Ratio	-0.54	-3.17	0.69	-0.71	0.49	1.16
Net Debt / FCF Ratio	-0.79	-3.54	0.96	-0.54	0.42	0.86
Asset Turnover	-	0.45	0.40	0.27	0.21	0.15
Inventory Turnover	-	2.49	3.74	12.25	6.09	6.11
Quick Ratio	2.29	2.05	1.20	1.01	1.25	1.55
Current Ratio	2.70	2.31	1.53	1.25	1.52	1.96
Return on Equity (ROE)	18.59%	11.48%	4.12%	-39.45%	-50.12%	-40.27%
Return on Assets (ROA)	-	4.30%	3.37%	-6.94%	-14.81%	-14.02%
Return on Invested Capital (ROIC)	19.72%	17.82%	10.76%	-31.99%	-71.53%	-76.89%
Return on Capital Employed (ROCE)	11.10%	7.60%	7.00%	-15.60%	-27.60%	-28.00%
Earnings Yield	0.67%	0.82%	1.05%	-8.82%	-6.64%	-
FCF Yield	0.69%	1.33%	5.46%	-4.68%	-6.00%	-
Payout Ratio	5.08%	8.69%	45.29%	-	-	-
Buyback Yield / Dilution	5.72%	3.93%	-5.26%	-4.54%	-5.13%	-180.82%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.